Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Holobiome

On the cellular level, humans are as much microbe as man -- for every human cell there is at least one bacterial cell either on our skin or inside of us. This enormous community of bacteria is our microbiome, and it has been shown to influence numerous components of human health, including metabolism, susceptibility to disease, and the immune response. Remarkably, recent evidence suggests the microbiome also influences diseases of the enteric and central nervous systems. Holobiome is developing a platform of microbiome-based therapeutics to treat these diseases. Our vision is to deliver this new class of drugs to patients and the marketplace.

  • Philip Strandwitz, PhD Co-Founder & CEO
  • Kim Lewis, PhD Co-Founder
  • Michael LaFleur, PhD Co-Founder